The world’s stockpile of cholera vaccines has run dry, bad news for cholera-ravaged southern Africa. Why is this and what is being done to address vaccine shortages in Africa?
David Higgins, University of Colorado Anschutz Medical Campus
A pediatrician and preventive medicine physician explains how measles vaccines became victims of their own success and the risk that rising outbreaks pose to everyone.
On the fourth anniversary of New Zealand’s first COVID case it’s clear this is not a normal pandemic. Despite fatigue and indifference, New Zealand must heed the evidence and improve its response.
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
An unexpected case of rabies found in an animal can raise concerns for a potential outbreak. Proactive vaccination of both wildlife and people can help protect everyone.
Currently we see more than 600,000 deaths from this mosquito-borne disease each year. This new vaccine – the second approved to treat malaria – could change things.
Chlamydia is devastating for koalas, but the vaccine to prevent infection requires a booster shot. Recapturing the animals for their booster shot is costly and stresses them, but there’s a solution.
No matter how much we believe our knowledge and our technological capabilities have evolved, pandemics prove we are still at the mercy of the natural world.
As COVID finds its equilibrium, infection rates will rise and fall, influenced by seasons, school holidays and new subvariants. Managing the risk is complex and needs to be cost effective.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand